ENvue Medical, Inc.
FEED
$1.16
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 312.00K | 722.00K | 494.00K | 1.03M | 444.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 312.00K | 722.00K | 494.00K | 1.03M | 444.00K |
| Cost of Revenue | 682.00K | 533.00K | 529.00K | 656.00K | 161.00K |
| Gross Profit | -370.00K | 189.00K | -35.00K | 369.00K | 283.00K |
| SG&A Expenses | 3.25M | 2.22M | 2.97M | 1.69M | 1.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.97M | 2.97M | 4.47M | 2.88M | 1.81M |
| Operating Income | -3.66M | -2.25M | -3.98M | -1.85M | -1.37M |
| Income Before Tax | -13.27M | 545.00K | -3.91M | -2.48M | -1.43M |
| Income Tax Expenses | -419.00K | 35.00K | 62.00K | 15.00K | 5.00K |
| Earnings from Continuing Operations | -12.85M | 510.00K | -3.97M | -2.50M | -1.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.85M | 510.00K | -3.97M | -2.50M | -1.43M |
| EBIT | -3.66M | -2.25M | -3.98M | -1.85M | -1.37M |
| EBITDA | -3.40M | -1.99M | -3.61M | -1.83M | -1.37M |
| EPS Basic | -12.37 | -0.91 | -1.03 | -39.85 | -37.76 |
| Normalized Basic EPS | -1.21 | 0.40 | -5.03 | -25.33 | -23.52 |
| EPS Diluted | -12.37 | -0.91 | -1.03 | -39.85 | -37.76 |
| Normalized Diluted EPS | -1.21 | 0.40 | -5.03 | -25.33 | -23.52 |
| Average Basic Shares Outstanding | 1.10M | 858.40K | 484.60K | 62.60K | 37.90K |
| Average Diluted Shares Outstanding | 1.10M | 858.40K | 484.60K | 62.60K | 37.90K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |